Interestingly, USP1 has been described as an oncogene in Acute Myeloid leukaemia (AML) [30], and USP1 inhibition has been shown to reduce primary AML cell growth by promoting degradation of the ID1 protein and disrupting homologous recombination [36]. The gene discussed is ID1; the disease is acute myeloid leukemia.